SNY vs. JNJ
Compare and contrast key facts about Sanofi (SNY) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SNY or JNJ.
Key characteristics
SNY | JNJ | |
---|---|---|
YTD Return | -1.01% | -7.75% |
1Y Return | -4.27% | -9.59% |
3Y Return (Ann) | 1.76% | -1.45% |
5Y Return (Ann) | 6.59% | 3.09% |
10Y Return (Ann) | 2.94% | 6.63% |
Sharpe Ratio | -0.17 | -0.64 |
Daily Std Dev | 26.65% | 15.04% |
Max Drawdown | -46.65% | -50.68% |
Current Drawdown | -10.82% | -18.33% |
Fundamentals
SNY | JNJ | |
---|---|---|
Market Cap | $122.65B | $352.17B |
EPS | $2.30 | $7.42 |
PE Ratio | 21.36 | 19.70 |
PEG Ratio | 0.84 | 0.89 |
Revenue (TTM) | $46.29B | $85.65B |
Gross Profit (TTM) | $31.70B | $63.95B |
EBITDA (TTM) | $12.20B | $30.67B |
Correlation
The correlation between SNY and JNJ is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SNY vs. JNJ - Performance Comparison
In the year-to-date period, SNY achieves a -1.01% return, which is significantly higher than JNJ's -7.75% return. Over the past 10 years, SNY has underperformed JNJ with an annualized return of 2.94%, while JNJ has yielded a comparatively higher 6.63% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SNY vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SNY vs. JNJ - Dividend Comparison
SNY's dividend yield for the trailing twelve months is around 3.86%, more than JNJ's 3.29% yield.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi | 3.86% | 3.82% | 4.22% | 3.80% | 3.61% | 3.46% | 4.29% | 3.67% | 4.03% | 3.77% | 4.19% | 3.47% |
Johnson & Johnson | 3.29% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% | 2.83% |
Drawdowns
SNY vs. JNJ - Drawdown Comparison
The maximum SNY drawdown since its inception was -46.65%, smaller than the maximum JNJ drawdown of -50.68%. Use the drawdown chart below to compare losses from any high point for SNY and JNJ. For additional features, visit the drawdowns tool.
Volatility
SNY vs. JNJ - Volatility Comparison
Sanofi (SNY) has a higher volatility of 7.88% compared to Johnson & Johnson (JNJ) at 4.50%. This indicates that SNY's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SNY vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Sanofi and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities